Loading...
•
Dec 31, 2024
Merit Medical Q4 2024 Earnings Report
Merit Medical Q4 2024 Earnings Report
Key Takeaways
Merit Medical reported revenue of $355.2 million for Q4 2024, up 9.4% year-over-year, with GAAP EPS of $0.46 and non-GAAP EPS of $0.93. The company achieved strong performance in revenue and profitability, supported by organic growth and acquisitions.
Revenue increased to $355.2 million, up 9.4% year-over-year.
GAAP EPS was $0.46, down 2.6% year-over-year.
Non-GAAP EPS improved to $0.93, up 25.8%.
Free cash flow generation was $65.3 million, up 18.4%.
Merit Medical
Merit Medical
Forward Guidance
Merit Medical expects continued revenue and profitability growth in FY 2025, driven by strong performance across key segments and ongoing strategic initiatives.
Positive Outlook
- Projected revenue growth of 8% - 10% year-over-year.
- Non-GAAP EPS guidance range of $3.58 to $3.70.
- Continued investment in growth initiatives.
- Focus on operational efficiency improvements.
- Strong pipeline of innovative medical solutions.
Challenges Ahead
- Potential impact of foreign currency fluctuations.
- Rising costs of raw materials.
- Ongoing regulatory compliance requirements.
- Competitive pressures in key markets.
- Potential macroeconomic uncertainties.